When Rare Childhood Cancers Gather:
A cancer cluster cannot be diagnosed from headlines—and no single exposure should be declared guilty without evidence. But “no cause has been established” is not a reason to stop looking.
Current reporting identifies six children from the area who were diagnosed with Ewing sarcoma, a rare cancer of bone and soft tissue. Reporters have since identified approximately a dozen cases involving several rare pediatric cancers in Ladera Ranch and other Orange County communities. One young woman, Haven Keetch, required an amputation after developing synovial sarcoma. Another teenager, Brody Matteson, died after battling Ewing sarcoma and treatment-related leukemia.
The cases have prompted an updated review by Orange County health authorities, community demands for greater disclosure of landscaping chemicals, a temporary pause on the routine use of certain landscape products, and a request from the First Assistant United States Attorney for the Central District of California that the Environmental Protection Agency investigate possible environmental causes.
No environmental cause has been established.
That sentence is scientifically necessary—but it must not become a conversation-ending slogan.
At RF Safe, we are not claiming that wireless radiation caused these cancers. We are not claiming that pesticides caused them. We are not claiming that every reported diagnosis belongs to one statistically confirmed cluster or shares one biological origin.
We are arguing that the investigation should not begin and end with a search for one chemical, one antenna, one mutation, or one guilty exposure.
It should ask a larger question:
Could multiple persistent environmental stressors be reducing the fidelity with which developing biology regulates calcium signaling, membrane voltage, mitochondrial metabolism, DNA integrity, gene expression, tissue repair and immune surveillance—creating an upstream state of vulnerability from which several different rare diseases can emerge?
RF Safe calls that proposed state low-fidelity biology.
First, determine whether this is a true cancer cluster
The National Cancer Institute defines a cancer cluster as a greater-than-expected number of cancers occurring in a defined population, geographic area and period. Several diagnoses in one community can be deeply concerning without necessarily constituting a statistically confirmed cluster. Population size, age distribution, diagnostic categories, residential history and the period under examination all affect the calculation.
That distinction is particularly important here.
Ewing sarcoma and synovial sarcoma are both rare sarcomas, but they are not the same disease. Ewing sarcoma is commonly driven by a chromosomal rearrangement joining EWSR1 to FLI1 or another ETS-family gene. Synovial sarcoma is characteristically associated with an SS18–SSX fusion. Grouping every uncommon pediatric malignancy into a single total may communicate the community’s suffering, but it does not automatically establish that the cancers are etiologically related.
Investigators must therefore establish:
- The exact diagnoses and molecular pathology of every reported tumor.
- Which children actually lived, attended school or regularly spent time in Ladera Ranch.
- Their ages at diagnosis and likely exposure windows.
- How long each family lived in the area.
- Whether cases occurred during the same biologically relevant period.
- The number expected in a comparable population.
- Whether the apparent concentration remains after correcting for age, migration, geography and the way the cases were discovered.
CDC guidance uses tools such as standardized incidence ratios, cancer-registry validation and spatial-temporal analysis to answer these questions.
But statistical confirmation is only the beginning. It does not identify the biological pathway or environmental cause.
The single-cause trap
Public discussion is already narrowing toward one question: Were pesticides responsible?
That is an appropriate hypothesis to investigate. Application records, product formulations, locations, quantities, drift, degradation products and prenatal or childhood exposure windows should all be examined. Temporarily reducing nonessential chemical use while an investigation proceeds is a rational precaution.
But the investigation should not be designed as a courtroom contest between “pesticides caused it” and “it was random.”
Biology is rarely exposed to one factor at a time.
A child may experience pesticide residues, traffic pollution, contaminated dust, artificial light at night, disrupted sleep, metabolic stress, infections, nutritional deficiencies, household chemicals and continuous electromagnetic exposures during the same developmental period. Some exposures may be irrelevant. Some may act independently. Others may modify the effects of another exposure or reduce the organism’s capacity to repair the damage it causes.
The correct unit of investigation is therefore not merely a suspect chemical. It is the child’s developmental exposome—the combined pattern of exposures interacting with the child’s inherited biology, acquired changes, age, health and developmental stage.
What RF Safe means by “low-fidelity biology”
Low-fidelity biology is a hypothesis, not a recognized medical diagnosis.
It describes a proposed upstream condition in which biological control systems continue to function, but do so with less temporal precision, lower signal-to-noise ratios and weaker resilience.
Healthy biology depends on more than the concentration of individual molecules. It depends on timing:
- When an ion channel opens.
- How long it remains open.
- The frequency and amplitude of a calcium oscillation.
- The phase relationship between membrane voltage and intracellular signaling.
- The timing of mitochondrial energy production.
- The balance between oxidant production and antioxidant recovery.
- The sequence in which genes are activated or silenced.
- Whether a damaged cell repairs itself, enters senescence, undergoes programmed death or escapes immune detection.
Calcium, for example, does not operate merely as an on-or-off chemical switch. Cells encode information in the amplitude, frequency, duration and spatial organization of calcium signals. Different oscillatory patterns can produce different transcriptional and metabolic outcomes.
In the low-fidelity model, chronic environmental stress does not have to create one disease through one linear pathway. It may instead degrade the accuracy of the upstream systems upon which many downstream processes depend.
That could manifest as impaired recovery, altered development, disturbed sleep architecture, metabolic dysfunction, reduced immune competence, abnormal inflammation, failed tissue repair or—under an unfortunate combination of events—a greater opportunity for rare cellular failures to survive.
We refer to this as a potential meta-disease state: not a disease itself, but a state that may increase susceptibility to several otherwise unrelated diseases.
This remains a research hypothesis. The Ladera Ranch cases do not prove it. But the hypothesis offers testable questions that a single-agent investigation may miss.
The receiver is part of the dose
Traditional exposure assessment often emphasizes what leaves the source: field strength, power density, frequency or specific absorption rate.
Those measurements matter, but they do not completely determine biological response.
The effective biological dose also depends on the receiver:
- Genetic variation.
- Gene regulation.
- Developmental stage.
- Tissue architecture.
- Membrane potential.
- Ion-channel density.
- Mitochondrial condition.
- Existing inflammation.
- Sleep and circadian state.
- Previous and simultaneous exposures.
A 2025 randomized, double-blind study illustrates this principle. Researchers exposed 34 genotyped participants to sham, 700 MHz and 3.6 GHz 5G signals before sleep. The 3.6 GHz exposure altered sleep-spindle center frequency in participants carrying one CACNA1C genotype but not in the matched comparison group. CACNA1C encodes the pore-forming subunit of an L-type voltage-gated calcium channel.
That study did not demonstrate cancer, disease or generalized harm from 5G. Its importance is more fundamental: two groups receiving the same external exposure did not show the same measured physiological response.
The receiver helped determine the dose.
This challenges any safety model that assumes absorbed energy alone can fully characterize biological effect across genetically and physiologically diverse populations.
From voltage sensing to calcium timing
Voltage-gated calcium channels contain specialized voltage-sensing structures, including positively charged S4 segments, that respond to changes in membrane potential and control pore gating.
These channels are not simply calcium “floodgates.” They are timing devices. Their activation, inactivation and recovery kinetics help shape calcium waveforms that regulate neuronal firing, muscle contraction, secretion, metabolism and gene expression.
An environmental perturbation would therefore not need to force a massive or sustained calcium influx to matter. A smaller change in channel timing, oscillatory frequency or synchronization could potentially alter the information encoded by the signal.
That distinction—between the quantity of calcium and the fidelity of its waveform—is central to the RF Safe hypothesis.
Why CYB5B changed the mechanistic discussion
A 2026 paper in Cell described an engineered electromagnetic-field-inducible gene switch capable of remotely controlling gene expression. Through mechanistic screening, the researchers identified cytochrome b5 type B, or CYB5B, as essential to the system and reported that it mediated EMF-specific calcium oscillations used to activate the switch.
This was a purpose-built biomedical system. It was not an experiment showing that ordinary cellular or Wi-Fi exposure causes cancer. It cannot be cited as proof that CYB5B mediates the effects of every electromagnetic waveform.
What it does establish is that an applied electromagnetic field can, under defined experimental conditions, be transduced through a specific biological mediator into rhythmic calcium activity that controls gene expression.
That is an important mechanistic proof of principle.
It directs attention away from the outdated assumption that an electromagnetic exposure matters only when it deposits enough average energy to heat tissue. It also shows why investigators must consider waveform, frequency, timing and biological transduction—not merely bulk temperature or average power.
Where wireless radiation fits—and where it does not
There is presently no evidence demonstrating that radiofrequency radiation caused the Ewing sarcoma, synovial sarcoma or other cancers reported around Ladera Ranch.
There are no publicly reported personal RF exposure histories, time-resolved neighborhood measurements or epidemiological analyses connecting local wireless infrastructure to these cases. No scientific basis presently exists for assigning RF exposure as the cause.
The tumor evidence also does not specifically point toward pediatric sarcomas. A 2025 systematic review of 52 animal studies found high-certainty evidence for increased gliomas and malignant cardiac schwannomas in male rats, while finding no or minimal evidence for tumors in most other organ systems, including the musculoskeletal system. The authors cautioned that translating animal results into human risk is complex and depends on unresolved questions about exposure metrics, intensity, modulation and dose-response relationships.
Similarly, the U.S. National Toxicology Program reported clear evidence of carcinogenic activity in male rats exposed to GSM- and CDMA-modulated radiofrequency radiation, based primarily on malignant heart schwannomas, with malignant gliomas also considered exposure-related. These were long-term, whole-body animal studies and cannot be directly mapped onto an individual child’s environmental exposure.
These findings do not implicate RF radiation in the Ladera Ranch sarcomas.
They do, however, provide sufficient evidence of biological and carcinogenic effects in experimental systems that chronic electromagnetic exposure should not be categorically excluded from a comprehensive environmental inventory before it is measured.
The responsible position is neither “wireless caused this” nor “wireless could not possibly matter.”
The responsible position is: measure it properly, examine it alongside other exposures, and test interaction hypotheses without prejudging the result.
Rare outcomes may be signals of upstream instability
The low-fidelity hypothesis does not predict that every environmentally stressed community will develop the same cancer.
It predicts something more complex: when the systems that maintain developmental and cellular fidelity are weakened, the resulting failures may depend on the tissue involved, developmental timing, inherited susceptibility, stochastic molecular events and concurrent exposures.
One child may possess a variant affecting calcium-channel regulation. Another may have reduced capacity to metabolize a chemical. Another may experience a crucial exposure during fetal development, puberty or a period of rapid tissue growth. A rare chromosomal rearrangement may occur in many cells but become clinically consequential only when repair, senescence, apoptosis or immune surveillance also fails.
Under this model, several different rare outcomes could represent distinct downstream manifestations of shared upstream instability.
That is a hypothesis—not an explanation of the Ladera Ranch cases. It would have to be tested against population controls, tumor biology, exposure histories and alternative explanations.
But it illustrates why the appearance of more than one rare tumor type should not automatically terminate an environmental investigation. Different tumors could argue against a common cause, but they could also indicate a shared influence acting upstream of tumor-specific initiating events.
What a comprehensive investigation should measure
A credible investigation should be independent, transparent and broad enough to test competing hypotheses.
1. Validate the cases
Investigators should confirm diagnoses through the California Cancer Registry and pathology records, distinguish primary cancers from treatment-related malignancies, establish molecular subtypes and construct accurate residential, school and activity histories.
2. Define the population and time window
The analysis must clearly define who is considered exposed, the geographic boundaries, the age groups, the period under review and the latency assumptions. Boundaries should not be drawn or repeatedly changed simply to maximize or minimize the apparent number of cases.
3. Reconstruct pesticide exposure
The investigation should obtain landscaping contracts, application logs, product names, active and inactive ingredients, dates, locations, weather conditions, drift potential and changes in practices over time. Prenatal, early-childhood, school, park and recreational exposures should be considered.
4. Evaluate the full environmental history
Testing should consider drinking water, irrigation water, soil, household dust, air pollution, traffic emissions, radon, metals, volatile organic compounds, PFAS and the historical use of the land.
5. Measure electromagnetic exposures
This should include both extremely low-frequency fields and radiofrequency radiation.
Measurements should not consist solely of a technician taking one broadband reading at one location. Investigators should document:
- Cellular frequencies and bands.
- Broadcast and public-safety sources.
- Wi-Fi and indoor wireless systems.
- Smart utility infrastructure.
- Peak and average fields.
- Duty cycles and temporal variation.
- Modulation and pulse characteristics.
- Nighttime bedroom exposures.
- Schools, parks and frequently used community areas.
- Personal device use and body proximity.
- Historical infrastructure changes.
These measurements would establish exposure—not causation. Their purpose would be to determine whether meaningful spatial or temporal patterns exist and whether those patterns justify deeper study.
6. Examine biological susceptibility
With informed consent and strong privacy protections, investigators could evaluate germline predisposition, tumor-fusion characteristics, secondary genomic alterations, DNA-repair pathways and metabolic or immune markers.
The purpose would not be to blame a child’s genetics. It would be to recognize that the same environmental exposure can produce different effects in different biological receivers.
7. Analyze mixtures and interactions
Studies should not assume that the effect of several exposures equals the sum of each exposure examined alone. Investigators should consider interactions among chemical exposure, sleep disruption, circadian light, metabolic state, infection, air pollution and electromagnetic fields.
8. Publish the methods and limitations
Families should receive the case definitions, statistical methods, exposure data, uncertainty estimates and reasons for including or excluding specific hypotheses. “No statistically significant excess” should not be presented as proof that no relevant exposure occurred, particularly when the population is small and the disease is extremely rare.
Precaution does not require a premature verdict
Communities do not need to wait for definitive causal attribution before reducing unnecessary exposures.
Nonessential pesticide applications can be replaced with less toxic practices. Indoor air can be filtered. Water and soil can be tested. Children’s sleep and light environments can be protected. Wireless devices can be kept away from the body, unnecessary transmitters can be disabled at night, and wired connections can be used where practical.
These are not cancer treatments, and they do not establish what caused any existing illness. They are low-cost measures that reduce avoidable environmental load while investigators search for answers.
Precaution becomes irresponsible only when it is used to spread certainty unsupported by evidence. Properly applied, it means acting proportionately under uncertainty while continuing to collect better evidence.
“No established cause” is not the same as “nothing happened”
Cancer-cluster investigations rarely identify a single environmental cause. The National Cancer Institute notes that, in a historical review of 576 suspected clusters, only 72 were confirmed as statistically elevated, three were linked to a possible exposure and one produced a clearly identified cause.
That history should create humility—not complacency.
Small populations, incomplete exposure records, migration, long latency periods and the crude nature of historical measurements make environmental causation extraordinarily difficult to reconstruct. Failure to identify a cause may mean that no shared cause existed. It can also mean that investigators lacked the data, statistical power or exposure model needed to detect one.
The families of Ladera Ranch deserve neither manufactured certainty nor institutional dismissal.
They deserve a scientifically disciplined investigation that asks:
- Is the number of cancers truly greater than expected?
- Are the cases geographically and temporally related?
- Do they share molecular features?
- Which exposures occurred during relevant developmental windows?
- Could several exposures have interacted?
- Were genetically or physiologically susceptible children affected differently?
- Were investigators measuring only chemical concentrations and average absorbed energy while missing biological timing and signal fidelity?
RF Safe is not declaring wireless radiation the cause of these cancers.
We are arguing that biology cannot be understood by studying one exposure, one pathway or one disease at a time.
The body is a dynamic electrical, chemical and metabolic system. The environment does not merely deliver isolated toxicants. It continuously interacts with that system—and the receiver is part of every dose.
When ultra-rare childhood diseases begin appearing close enough together to alarm families, the first obligation is not to select a villain.
It is to measure everything that can reasonably be measured, protect children wherever exposure can reasonably be reduced, and investigate whether the deeper problem is not one downstream disease but a preventable loss of biological fidelity upstream.
